drugset / Trial / NCT02945449
Safety of Wharton Jelly in Erectile Dysfunction
NaSingle-groupOpen-labelTreatment
Summary
Safety of Intracavernous injection of Wharton jelly Mesenchymal stem cells for the treatment of erectile dysfunction in diabetic patients.
Timeline
- Start
- 2017-01-04
- Primary completion
- 2018-10-15
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Wharton Jelly Mesenchymal stem cells | Cell therapy | 20 cells | Other |